Anti-SARS-CoV-2 antibodies test

Print Friendly, PDF & Email

Anti-SARS-CoV-2 antibodies test

Łukasiewicz – PORT offers anti-SARS-CoV-2 antibodies test in Wrocław.

Coronavirus Microblot Array COVID-19 is quantitative multi-parameter test for the determination of anti-SARS-CoV-2 antibodies.

A detailed price list containing special offers can be found here.

Test allows to determine full post-infection and post-vaccination immunity in one test!

The SARS-CoV-2 coronavirus contains several proteins (antigens) that are highly immunogenic, i.e., they cause the production of antibodies that protect against COVID-19.

Most antibody detection tests identify only one type of antibody, either antibodies that indicate vaccination immunity or indicate post-infective (health) immunity.

The great advantage of the Microblot Array test, which detects specific antibodies to several key antigens of the SARS-CoV-2 virus, is the ability to identify both types of immunity.


  1. Identifies patients who have developed COVID-19 and developed healing immunity.
  2. Determines the level of antibodies neutralizing anti-SARS-CoV-2 proteins, produced both after infection and being the main antibodies proving immunity after vaccination.
  3. Differentiates SARS-CoV-2-specific antibodies from antibodies created in contact with human coronavirus, which are responsible for mild colds ( NL63 or 229E).
  4. Differentiates SARS-CoV-2 specific antibodies from those produced in contact with other highly infectious coronaviruses such as SARS-CoV and MERS-CoV.

The test enables the simultaneous detection of specific antibodies for several SARS-CoV-2 markers:

  • The RBD domain (S1 subunit of the S peak protein) is the most important antigen used to monitor immunity after vaccination. RBD antibodies have strong virus neutralizing properties. Their presence confirms the acquisition of resistance to COVID-19. All vaccines available on the market (Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson) are directed to produce this type of antibodies.
  • Protein S2 (part of the peak protein) responsible for the virus binding to the host cell. Antibodies to S2 are present and produced after infection.
  • The NP nucleocapsid protein that surrounds the genetic material of the virus. The presence of NP antibodies indicates post-infection immunity, the so-called healing.
  • PLPro – papain-like protease, a key virus enzyme that weakens the human immune system. The presence of an anti-PLPro antibody indicates COVID-19 infection.

The high degree of consistency between the results of the Microblot Array for RBD antibodies and the results obtained with the VNT virus neutralization test, which is considered an indicator of the “performance” of antibodies, guarantees the reliability of the information as to whether the detected antibody concentration has a protective effect.

Thanks to the compliance with the International Standards WHO 20/136 and NIBSC, the Microblot Array COVID-19 test can be used to monitor the concentration of antibodies after vaccination.




Cost: PLN 110 (one test)


Cost: PLN 100 (one test)

Directed to:

People who have received at least one dose of the COVID-19 vaccine approved in Poland.*

People who have performed the RT-qPCR test for SARS-COV-2 virus infection at the Łukasiewicz – PORT collection points as part of private research.**

* Please show the vaccination card or the EU COVID Certificate QR code before the examination.

** Offer for patients who performed the COVID-19 test from May 1, 2021.



Cost: PLN 190

The price includes the execution of 2 tests:

First test – min. 2 weeks after vaccination.

Second test – up to 8 months after the first test. *

* The package is completed within 8 months from the date of purchase



Cost: PLN 240

The price includes 3 tests:

First test – before vaccination.

Second test – min. 2 weeks after vaccination.

Third test – up to 6 months after the first test.*

* The package is completed within 8 months from the date of purchase


Services for employers, healthcare entities and the public sector according to an individual agreement and a preferential price offer.


How is the test performed?

A venous blood sample of approximately 3 ml will be collected for the purposes of the test. The collection will be performed by qualified medical staff of the Centre for Population Diagnostics. The study does not require additional preparation – You do not need to be fasting before the test.


We take test samples at the Mobile Collection Point (a container in the campus yard).

  • Opening days: Wednesday, Thursday, Friday.
  • Opening hours: 7.30 a.m. – 10 a.m.

You can get to the Pracze Campus:

  • by train (to Wrocław-Pracze station), 
  • by bus lines 101 and 103 (Pracze Odrzańskie – Kolejowa stop), 
  • by car – free parking is available on site.

How will I receive my test results?

The results of the test will be available after each test on a dedicated website at: Link to the platform can also be found at


Population Diagnostics Center – Diagnostic Laboratory

Łukasiewicz research network – PORT Polish Center for Technology Development

Stabłowicka 147 St.

54-066 Wrocław

telefon 887 781 072


Print Friendly, PDF & Email